Copyright © Inderes 2011 - present. All rights reserved.
Log in to your Inderes Free account to see all free content on this page.
Create account

Medistim

Less than 1K followers

MEDI

Oslo Børs

Medical Equipment & Services

Health Care

Medistim is active in ultrasound technology. The company develops and commercializes medical equipment for use in cardiovascular and transplant surgery. The company strives to reduce risks and improve quality by using transit time flow measurement and high-frequency ultrasound imaging. Medistim has subsidiaries and distributors in markets around the world. Its customers are public and private hospitals and the company is headquartered in Norway.

Read more
Market cap
-
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
6.5.
2026

General meeting '26

7.5.
2026

Interim report Q1'26

7.5.
2026

Annual dividend

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Forum discussions
Opening a thread and discussion about an interesting health technology company on the Oslo Stock Exchange. Are there any Medistim investors on the forum? Medistim ASA is a Norwegian listed company that develops, manufactures, and distributes medical devices primarily for cardiovascular...
4/4/2022, 11:41 AM
by Niinpaljonturskaa
17
Medistim reported Q4 results yesterday, Friday, and the results clearly exceeded market expectations. Revenue grew by over 20% and EBIT improved by as much as 64% YoY. Growth was driven especially by sales in the Americas, where the company had a difficult couple of years. APAC was...
2/28/2026, 9:44 AM
by Tyhjätasku
6
Medistim published its Q3 results yesterday. There was a bit of excitement on my part, as the company had promised to raise prices with new product features and to mitigate the impact of tariffs. I wondered what effects this would have on demand and if the company’s pricing power...
10/25/2025, 9:28 AM
by Tyhjätasku
6
Medistim has been in the portfolio since the beginning of the year and has been mentioned in previous portfolio reviews What I believe makes the company very attractive is its recurring revenue. The company sells sensors that can be used 50-100 times depending on the sensor, after...
9/16/2025, 7:07 PM
by Tyhjätasku
5
It would be nice to hear comments from other esteemed forum members about this company as well. How does this sound: 80% gross margins Over 30% ROIC Strong balance sheet Cash flows into the coffers Niche area of expertise Market leader in some areas Quality company? Perhaps on the...
9/16/2025, 6:17 PM
by Thyme
3
Medistim’s stock has fallen from previous high valuation levels, which, according to the tweeter, makes the risk-reward ratio attractive. The company invests in innovations that apparently strengthen its competitive advantage. Strong cash flow, high margin, and dividend yield make...
3/22/2025, 10:19 AM
by Sijoittaja-alokas
3
Q4 and 2022 results out medistim.com Company Disclosures: Medistim's Transparency & Corporate Governance Stay informed with Medistim's Company Disclosures page, offering transparent updates on corporate governance, financial performance, and strategic decisions. Learn more. "Another...
3/1/2023, 7:25 AM
by Niinpaljonturskaa
3
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.